IBIObenzinga

iBio's First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss And Shows Synergy With GLP-1s In Preclinical Model; Strong Synergistic Effect On Fat Mass (77% Reduction) Was Observed When The Activin E Antibody Was Combined With A

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on May 5, 2025 by benzinga